Accessory spleen mimicking pancreatic tumour: evaluation by 99mTc-labelled colloid SPECT/CT study. Report of two cases and a review of nuclear medicine methods utility by Pachowicz, M. et al.
Folia Morphol. 
 Vol. 74, No. 4, pp. 532–539
DOI: 10.5603/FM.2015.0119 
Copyright © 2015 Via Medica
ISSN 0015–5659 
www.fm.viamedica.pl
C A S E   R E P O R T
532
Address for correspondence: M. Pachowicz, MD, Chair and Department of Nuclear Medicine, Medical University of Lublin, ul. Jaczewskiego 8c, 
20–954 Lublin, Poland, tel/fax: +48 81 724 43 39, e-mail: marcin.pachowicz.md@gmail.com
Accessory spleen mimicking pancreatic tumour: 
evaluation by 99mTc-labelled colloid SPECT/CT  
study. Report of two cases and a review of  
nuclear medicine methods utility
M. Pachowicz1, 2, A. Mocarska3, E. Starosławska3, Ł. Pietrzyk2, 4, B. Chrapko1
1Chair and Department of Nuclear Medicine, Medical University of Lublin, Poland 
2Department of Didactics and Medical Simulation, Medical University of Lublin, Poland 
3St. John’s Cancer Centre, Lublin, Poland 
4General and Minimally Invasive Surgery Department, 1st Clinical Military Hospital, Lublin, Poland
[Received 31 August 2014; Accepted 13 January 2015]
The accessory spleen is a common congenital anomaly, typically asymptomatic 
and harmless to the patient. However, in some clinical cases, this anomaly beco-
mes significant as it can be mistaken for a tumour or lymph node and be missed 
during a therapeutic splenectomy.
There are nuclear medicine modalities which can be applied in the identification 
and localisation of an accessory spleen. They include scintigraphy with radiolabelled 
colloids or heat damaged red blood cells, which are trapped in the splenic tissue. 
Modern techniques, including hybrid imaging, enable simultaneous structure and 
tracer distribution evaluations. Additionally, radiation-guided surgery can be used 
in cases where the accessory spleen, which is usually small (not exceeding 1 cm) 
and difficult to find among other tissues, has to be removed.
In the study, we would like to present 2 cases of patients in which the malignancy 
had to be excluded for the reason that the multiple accessory spleens were very 
closely related to the pancreas. There was a lack of certainty in the multi-phase 
computed tomography (CT) evaluation; however, this situation was clearly resolved 
by using the 99mTc-stannous colloid single photon emission computed tomography/
CT study. We would also like to briefly analyse the clinical applications of nuclear 
medicine in case of an accessory spleen. (Folia Morphol 2015; 74, 4: 532–539)
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INTRODUCTION
The spleen is an intraabdominal, intraperitoneal 
organ consisting of vascular and lymphoid tissue. It is 
located in the upper left quadrant of the abdominal 
cavity, right below the diaphragm, protected by the 
lower left ribs [8].
The spleen develops from a number of separated 
foci, which then fuse together to form one single 
organ. There are multiple congenital anomalies of 
the spleen including complete agenesis, polysplenia 
(multiple spleens), accessory spleens (ASs) or persi-
stent lobulation [5, 13].
The presence of an AS is very common, reported 
in even up to 30% of the population. Its location may 
vary, but typically it is located close to the “main” 
spleen. Usually, an anomaly such as this is completely 
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asymptomatic and harmless, but in some conditions 
it can be significant. It is very important to recognise 
an AS, distinguish it from lymphadenopathy or tu-
mour and locate it prior to a splenectomy in case of 
autoimmune disorders [5].
We are going to present 2 cases of patients with 
ASs in whom the correct identification of this anomaly 
was extremely important. These patients underwent 
contrast enhanced computed tomography (CT) at the 
St. John’s Cancer Centre in Lublin to exclude distant 
metastases or intrapancreatic tumour. In both cases, 
the radiologists were not absolutely sure about the 
nature of the observed lesions. The problem was solved 
with the 99mTc-labelled stannous colloid single photon 
emission computed tomography (SPECT/CT) study.
SPECT/CT study protocol. In both cases the acqui-
sition was performed 20 min after 99mTc-stanous col-
loid intravenous injection. The administrated activity 
was 185 MBq. A Symbia T16 SPECT/CT (Siemens, 
Erlangen, Germany) gamma camera was used. The 
SPECT scan consisted of 64 views (dual head gamma 
camera), 25 s for each with head movement of 3° be-
tween views. Additionally, the low dose CT (130 keV, 
40 mAs) was done to provide an attenuation correc-
tion and anatomical correlation.
CASE REPORT
Patient 1. 60-year-old female with breast cancer 
history. She underwent surgery on her right bre-
ast (breast conserving therapy) along with axillary 
lymphadenectomy. Additionally, she underwent che-
motherapy and radiotherapy. After the treatment 
there were no signs of local recurrence or distant 
metastases, nonetheless, she was admitted to the 
Radiology Department at St. John’s Cancer Centre 
for routine 3-phase CT study to exclude metastatic 
disease.
The abdomen scan revealed a suspicious tissue mass 
linked to the tail of the pancreas which was characteri-
sed by significant contrast enhancement. The radiologist 
was not able to identify the boundary between the 
pancreas and this mass. It was initially identified as an 
accessory spleen, but the radiolabelled colloid study was 
recommended to rule out other aetiologies.
This study was performed according to the pro-
tocol presented above. 
In the SPECT study, there was only one isolated 
activity area located below the spleen. In the fused 
images, there was a round tissue mass corresponding 
to this area — the AS (Figs. 1, 2).
Moreover, fused SPECT/CT images clearly indicated 
that there was activity coming from the suspicious 
tissue mass connected to the pancreatic tail, so the 
AS was also confirmed (Figs. 3, 4).
Patient 2. 63-year-old female, admitted to the 
St. John’s Cancer Centre Radiology Department for 
further evaluation due to suspicious tissue mass diag-
nosed during abdominal CT.
Contrast enhanced study displayed this tissue 
mass located at the tail of pancreas. Additionally 
several small AS were found.
In the SPECT images, there was additional activity 
in the area close to the splenic hilum. In the fused 
images, this activity was related to the tail of the 
pancreas and the tissue mass located there; proving 
it to be intrapancreatic AS (Figs. 5, 6).
One more AS was identified in the SPECT/CT scans 
(Figs. 7, 8). The additional ASs reported in the primary 
CT study were not localised, probably due to low 
SPECT spatial resolution.
 Both patients remain under control.
DISCUSSION
The spleen’s development begins in the dorsal 
mesogastrium cranial part in approximately the 6th 
week of embryologic life. As mention above, the cells’ 
proliferation and infiltration takes place in several 
adjoining points, which later fuse to form one single 
organ. This lobulated structure can be observed as 
spleen margin notches in adulthood, but sometimes 
more prominent lobulation persists as an anomaly. 
The AS is formed as an ectopic or separated splenic 
tissue located anywhere from the point of spleen 
origin in the midline to its final location in the left 
hypochondrium [13], but not only.
The ASs (also called ‘splenules’ or ‘splenunculi’) 
can be observed in 10–30% of adults during autopsy 
and in 15–16% of CT studies. Only 0.2% of patients 
have more than one AS during a CT [5, 6, 13]. The 
reported incidence of AS is: 1 AS — 79–86%, 2 ASs 
10.5–14% and 3 ASs — 1–10.5% among all indi-
viduals with an AS. Unver Dogan et al. [13] repor-
ted a total number of 54 ASs in 48 patients during 
720 autopsies, 91.6% of the patients had 1 AS. In 
some cases, there can be as many as 6 ASs, very 
rarely more [2, 15].
Most often, ASs are located close to the splenic 
hilum (75%), but can also be found at the tail of the 
pancreas (16–25%), less frequently in the greater 
omentum, in the wall of bowel or stomach, mesen-
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Figure 1. Patient 1. A, B, C. Multi-phase computed 
tomography (CT): pre-contrast, arterial and delayed 
phases, respectively. Axial scans. Accessory 
spleen located below the main spleen (arrow);  
D, E, F. Radionuclide study: CT, pure single photon 
emission computed tomography (SPECT) and 
fused SPECT/CT images. Axial scans. Radiotracer 
uptake confirming accessory spleen.
Figure 2. Patient 1. Radionuclide study: computed 
tomography (CT), pure single photon emission 
computed tomography (SPECT) and SPECT/CT 
scans. Axial, sagittal and coronal scans. Accessory 
spleen located below the “main” spleen (arrow). 
Also note slight radiotracer uptake in bone morrow 
of vertebrae.
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Figure 3. Patient 1. Similarly to Figure 1. A, B, C, D. 
Note radiotracer uptake in both “main” and  
accessory spleens is indistinguishable in pure single 
photon emission computed tomography (SPECT) 
scan (E). SPECT/CT fused images (F) clearly show 
the source of activity in the accessory spleen  
located behind the pancreatic tail (arrow).
Figure 4. Patient 1. Similarly to Figure 2. In all single 
photon emission computed tomography scans 
activity from “main” and accessory spleen merges 
so the accessory spleen cannot be clearly identified. 
Fused functional-anatomical images make this 
identification much easier (arrow). Note also slight 
activity in the pelvicocalyceal system coming from 
the radiotracer excreted with urine.
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Figure 5. Patient 2. Similarly to Figure 1. The  
intrapancreatic accessory spleen located in  
the tail, close to the splenic hilum (arrow).
Figure 6. Patient 2. Similarly to Figure 2. The  
intrapancreatic accessory spleen (arrow).
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Figure 8. Patient 2. Similarly to Figure 2. The small 
accessory spleen (arrow).
Figure 7. Patient 2. Similarly to Figure 1. One 
more small accessory spleen indicated by slightly 
increased activity anteriorly to the “main” spleen 
(arrow).
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tery, pelvis, broad ligament, left ovary and even the 
scrotum. Sometimes they can be retroperitoneal. 
Usually they are small, not exceeding 1 cm in diameter 
[2, 10, 13, 15].
Normally, AS is a completely asymptomatic con-
dition and is detected accidentally, but in several 
clinical cases ASs may become significant and tricky 
to evaluate by the physicians. 
The 99m-technetium labelled colloids (sulphur or 
stannous) injected intravenously are rapidly uptaken by 
the reticuloendothelial system in the liver and spleen. 
The colloids are also accumulated in the bone mar-
row. Modern nuclear medical techniques, mainly the 
SPECT/CT provide structural data along with radiotracer 
distribution reflecting the observed structures’ molecu-
lar behaviour. Such fused functional — SPECT — and 
anatomical — CT — images are especially helpful since 
SPECT scans have relatively low spatial resolution. They 
enable quick AS identification [10, 11].
Alternatively, radiolabelled heat damaged red 
blood cells (99mTc-HDRBC) can be used. Since the 
spleen is responsible for sequestration and destru-
ction of old and damaged erythrocytes, radioacti-
ve HDRBC are also quickly trapped by this organ. 
A similar result can be obtained by using magnetic 
resonance imaging with ferumoxides [10].
One of the most important clinical cases is the 
differentiation between the intrapancreatic AS and 
a pancreatic tumour. In such cases, both nuclear me-
dicine methods can be applied since both colloids and 
HDRBC are highly specific and activity in the AS can be 
observed after injection. The metastases must also be 
excluded when an intrapancreatic lesion is observed. 
The characteristic appearance of tissue masses related 
to the pancreas is presented in Table 1 [7, 10].
Groshar et al. [6] evaluated 73 malignancy pa-
tients (36 solid tumours and 37 lymphomas) with 
accessory spleen-like mass (ASLM) by using the 
fluorine-18-fluorodeoxyglucose (18F-FDG)-positron 
emission tomography. During the control study, ASLM 
presented no changes confirming an AS in 69 of 
the cases. The remaining 4 patients suffered from 
lymphoma: in 3 patients the ASLM disappeared after 
chemotherapy indicating an involved lymph node, 
Table 1. Characteristics of intrapancreatic tissue masses in various diagnostic modalities [7, 10]
Modality IPAS Neuroendocrine tumour Metastases
Contrast-enhanced ultrasonography
Arterial phase Hyperechoic to pancreas 
Isoechoic to spleen
Hyperechoic to pancreas
Usually multiple  
with heterogeneous  
enhancementPortal/delayed phase Typically prolonged,  
persistent enhancement
Typically prolonged, persis-
tent enhancement absent
Computed tomography
Arterial phase Heterogeneous  
enhancement
Small lesions: homogeneous or rim-like enhancement 
Large lesions: heterogeneous enhancement with necrotic foci
Portal/delayed phase Persistently hyperdense  
to pancreas 
Isodense to main spleen
Iso- or hypodense, rarely calcifications
Magnetic resonance imaging
Precontrast T1 weighted images Hypointensive to pancreas 
Isointensive to spleen
Hypo- or isointensive  
to pancreas
Hypointensive to pancreas
Precontrast T2 weighted images Hyperintensive to pancreas 
Usually isointensive to spleen
Hyper- or isointensive 
to pancreas
Hyper- or hypointensive to  
pancreas depending on size
Gadolinium enhanced T1 weighted images Similarly to dynamic computed tomography
Radionuclide studies
99mTc-colloid scintigraphy Radiotracer uptake present Radiotracer uptake absent Radiotracer uptake absent
99mTc-HDRBC scintigraphy Radiotracer uptake present Radiotracer uptake absent Radiotracer uptake absent
Somatostatin receptor scintigraphy Radiotracer uptake  
occasionally present 
Radiotracer uptake  
typically present depending 
on tumour’s character
Radiotracer uptake absent
IPAS — Intrapancreatic accessory spleen; 99mTc — metastable technetium-99; HDRBC — heat damaged red blood cells
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1 patient presented an increased FDG uptake reflec-
ting AS involvement [6]. This study strongly suggests 
that not all ASLM are benign, especially in cases of 
lymphoma patients. We should be careful.
The second important clinical case involved a pa-
tient after splenectomy. In such cases, AS will grow 
overtaking the removed organ’s function, and an 
unexpected tissue mass can be observed in the ab-
dominal cavity. Recently, Wang et al. [14] reported 
an AS arising from the gastric fundus mimicking 
a gastrointestinal stromal tumour. Toutzioris et al. [12] 
reported compensatory enlargement of the AS mimi-
cking a retroperitoneal tumour.
The possible presence of an AS should be kept in 
mind during endoscopic ultrasonography. It can also 
be mistakenly taken as a tumour during this study [2].
One of the most interesting conditions is sple-
nosis, observed sometimes in patients after severe 
trauma followed by a splenectomy. It is an example 
of spleen remnants autotransplantation. These dis-
seminated in the abdominal cavity small spleens can 
mimic multiple metastases. Franceschetto et al. [4] 
reported a case of suspected hepatocellular cancer 
metastases where the 99mTc-sulfur colloid scan con-
firmed splenosis and spared the patient from more 
invasive diagnostic procedures. An example of in-
trathoracic splenosis, also confirmed by colloid scan, 
was reported by Bhalani et al. [3].
Nuclear medicine methods can also be used in 
spleen surgery. In some autoimmune disorders sple-
nectomy is a therapeutic procedure and in such cases 
it is crucial to remove all the spleens. If any of the 
spleens are missed, the patient’s condition will not 
improve after surgery, or will improve only for a short 
period of time. In cases of idiopathic thrombocyto-
poenic purpura, up to 18% of patients have a relapse 
due to residual or undetected splenic tissue. The sur-
geon may use a gamma probe to detect the radiation 
coming from an injected tracer. Such methods are 
used on a daily basis in departments of nuclear medi-
cine when searching for the sentinel lymph node. This 
radiation-guided surgery may significantly shorten 
the operation time, allow for a laparoscopic proce-
dure instead of laparotomy, increase confidence that 
all ASs have been removed and help avoid another 
surgery. In such cases HDRBC should be preferred as 
more specific method than colloids [1, 9].
CONCLUSIONS
Nuclear medicine provides easy, inexpensive, safe 
and quick spleen identification methods, which can 
be successfully applied in a variety of clinical cases 
and can be expanded into the field of surgery.
These diagnostic imaging and radiation guided sur-
geries should be well-known for physicians since they 
can be very helpful in proper patient management. 
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